Newspaper Clipping of Unaudited Financial Results for Quarter and Half Year ended September 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has submitted to BSE the newspaper advertisement of its standalone unaudited financial results for the second quarter and first half of FY2026 (period ended September 30, 2025). This is a routine SEBI LODR compliance filing, where listed companies must publish their quarterly/half-yearly results in a newspaper and share the clipping with the exchange. The covering letter is signed by Managing Director Chintan Didawala Ganpat (DIN: 11088268) on November 15, 2025. The actual numbers from the newspaper clipping are not legible in the document provided, so revenue, profit and other figures cannot be reported from this filing alone.
This is a procedural disclosure with no fresh information for investors beyond what is already captured in the company's earlier results filing. Shareholders should refer to the separately filed unaudited financial results for the actual performance numbers.